OCON Therapeutics
PrivateLast Round
VC Round
Jun 24, 2024
Total Funding Raised
$1.7M
Company Overview
OCON Therapeutics is a health tech and life sciences company that develops, manufactures, and commercializes intrauterine drug-delivery technologies for women's health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OCON Therapeutics Comparables
Compare OCON Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eurogine S.L. | 80% | |
| Sebela Pharmaceuticals | 78% | |
| 3Daughters | 78% | |
OCON Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 24, 2024 | ||||
| VC Round | Dec 18, 2020 | ||||
| VC Round | Jun 22, 2020 | ||||
| Strategic | Oct 19, 2017 | ||||
| Seed | May 7, 2013 |
OCON Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Exerte Partners | VC Round |
| Israel Innovation Authority | VC Round |
| Features Capital | VC Round |
| Astia Angels | VC Round |
| Pontifax Venture Capital | VC Round, Seed |
| Docor International Management | VC Round, Seed |
| RH Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2020
Rhia Ventures led the round with participation from Pontifax, Astia Angels, and Israel Innovation Authority.
- Jun 22, 2020
$2M round led by Pontifax Venture Capital.
OCON Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OCON Therapeutics's valuation, stock price, and market status.